ArticleClinical & translational immunology2023

Administration of an LXR agonist promotes atherosclerotic lesion remodelling in murine inflammatory arthritis.

Dragana Dragoljevic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.